Presentation is loading. Please wait.

Presentation is loading. Please wait.

Physician and Patient Influences on Provider Performance

Published byFrida Haraldsen Modified over 6 years ago

Similar presentations

Presentation on theme: "Physician and Patient Influences on Provider Performance"— Presentation transcript:

1 Physician and Patient Influences on Provider Performance
by Ellen Funkhouser, Thomas K. Houston, Deborah A. Levine, Joshua Richman, Jeroan J. Allison, and Catarina I. Kiefe Circ Cardiovasc Qual Outcomes Volume 4(1):99-106 January 18, 2011 Copyright © American Heart Association, Inc. All rights reserved.

2 Proportion of post–MI patients prescribed β-blockers by comorbidity (not mutually exclusive): the MI-Plus Study, 2003 to 2007. Proportion of post–MI patients prescribed β-blockers by comorbidity (not mutually exclusive): the MI-Plus Study, 2003 to 2007. Ellen Funkhouser et al. Circ Cardiovasc Qual Outcomes. 2011;4:99-106 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "Physician and Patient Influences on Provider Performance"

Similar presentations

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,
Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,
Discontinuation of medication after nonfatal event: MI

Discontinuation of medication after nonfatal event: MI
by Hiroyuki Morita, and Issei Komuro

by Hiroyuki Morita, and Issei Komuro
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏
Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.

Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.
CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Similar presentations

Ads by Google